+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cervical Cancer Diagnostic Test Market and Others for Hospitals, Laboratories and Other End-users - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

  • ID: 4853358
  • Report
  • September 2016
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the cervical cancer diagnostic test market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the cervical cancer diagnostic test market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cervical cancer diagnostic test market on a global level.

This report offers comprehensive coverage on global cervical cancer diagnostic test market along with market trends, drivers, and restraints of cervical cancer diagnostic test market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the cervical cancer diagnostic test market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the cervical cancer diagnostic test market by segmenting the market based on the type of test, end- users and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The test type market covered under this study includes Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC) and others (cone biopsy and loop electrosurgical excision procedure). The end-user segment includes hospitals, laboratories, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. These regions are further segmented into the U.S., UK, Germany, France, Japan, China, India and Brazil.  

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global cervical cancer diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.

This report segments the global cervical cancer diagnostic test market as follows:

Global Cervical Cancer Diagnostic Test Market: Test Analysis

  • Pap Smear Tests
  • Colposcopy
  • HPV Testing
  • Endocervical Curettage (ECC)
  • Others {Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)

Global Cervical Cancer Diagnostic Test Market: End- User Analysis

  • Hospitals
  • Laboratories 
  • Others

Global Cervical Cancer Diagnostic Test Market: Regional Segment Analysis

  • North America
  • US
  • Europe
  • UK
  • Germany
  • France 
  • Asia Pacific
  • China 
  • Japan 
  • India
  • Latin America
  • Brazil
  • Middle East And Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Cervical Cancer Diagnostic Test Market, 2015 - 2021 (USD Billion)
    • 2.2. Global Cervical Cancer Diagnostic Test Market: Snapshot
  • Chapter 3. Cervical Cancer Diagnostic Test – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global Cervical Cancer Diagnostic Test Market Drivers: Impact Analysis
      • 3.3.2. Rapid Spread Of Human Papillomavirus (HPV) Infection
      • 3.3.3. Having Multiple Sex Partners
    • 3.4. Market Restraints
      • 3.4.1. Global Cervical Cancer Diagnostic Test Market Restraints: Impact Analysis
      • 3.4.2. Lack Of Education Regarding The Prevalence Of Cervical Cancer
    • 3.5. Opportunities
      • 3.5.1. Covering Untapped Market
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, By Test Segment
      • 3.7.2. Market Attractiveness Analysis, By End- Users Segment
      • 3.7.3. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global Cervical Cancer Diagnostic Test Market – Competitive Landscape
    • 4.1. Company Market Share, 2015 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Regional Expansion
    • 4.3. Type Portfolio
  • Chapter 5. Global Cervical Cancer Diagnostic Test Market – Test Analysis
    • 5.1. Global Cervical Cancer Diagnostic Test Market: Test Overview
      • 5.1.1. Global Cervical Cancer Diagnostic Test Market Revenue Share, By Test , 2015 And 2021
    • 5.2. Pap Smear Tests
      • 5.2.1. Global Pap Smear Tests Market, 2015 – 2021 (USD Billion)
    • 5.3. Colposcopy
      • 5.3.1. Global Colposcopy Market, 2015 – 2021 (USD Billion)
    • 5.4. HPV Testing
      • 5.4.1. Global HPV Testing Market, 2015 – 2021 (USD Billion)
    • 5.5. Endocervical Curettage (ECC)
      • 5.5.1. Global Endocervical Curettage (ECC) Market, 2015 – 2021 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global Other Cervical Cancer Diagnostic Test Market, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Cervical Cancer Diagnostic Test Market – End- Users Analysis
    • 6.1. Global Cervical Cancer Diagnostic Test Market: End- Users Segment Overview
      • 6.1.1. Global Cervical Cancer Diagnostic Test Market Revenue Share, By End- Users, 2015 And 2021
    • 6.2. Hospitals
      • 6.2.1. Global Cervical Cancer Diagnostic Test Market For Hospitals , 2015 – 2021 (USD Billion)
    • 6.3. Laboratories
      • 6.3.1. Global Cervical Cancer Diagnostic Test Market For Laboratories, 2015 – 2021 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global Cervical Cancer Diagnostic Test For Others End- Users Market, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Cervical Cancer Diagnostic Test Market – Regional Segment Analysis
    • 7.1. Global Cervical Cancer Diagnostic Test Market: Regional Overview
      • 7.1.1. Global Cervical Cancer Diagnostic Test Market Revenue Share, By Region, 2015 And 2021
    • 7.2. North America
      • 7.2.1. North America Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 , (USD Billion)
      • 7.2.2. North America Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 , (USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.3.2. Europe Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021, (USD Billion)
        • 7.3.3.2. Germany Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021, (USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021, (USD Billion)
        • 7.3.4.2. France Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021, (USD Billion)
      • 7.3.5. UK
        • 7.3.5.1. UK Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.3.5.2. UK Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.4.2. Asia Pacific Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.4.3.2. China Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.4.4.2. Japan Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.4.5.2. India Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.5.2. Latin America Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.5.3.2. Brazil Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.6. Middle East And Africa
      • 7.6.1. Middle East And Africa Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East And Africa Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Abbott Laboratories
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Becton, Dickinson and Company
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Femasys, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Hologic, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Guided Therapeutics, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. OncoHealth Corp.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. Quest Diagnostics, Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Roche Diagnostics
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. QIAGEN
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments
    • 8.10. Zilico Ltd
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll